The Leadership Team at Carmell Therapeutics is responsible for setting the strategic direction and overseeing the overall operations of the company. Comprising key executives, including the CEO, Chief Quality Officer, and Chief Medical Officer, the team collaborates to ensure the effective development and commercialization of innovative biologically-active plastics derived from blood plasma, focusing on advancing treatments for bone and connective tissue injuries.
View all